A detailed history of Nuveen Asset Management, LLC transactions in Veru Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 178,557 shares of VERU stock, worth $126,775. This represents 0.0% of its overall portfolio holdings.

Number of Shares
178,557
Previous 178,557 -0.0%
Holding current value
$126,775
Previous $149,000 8.05%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.76 - $1.79 $135,703 - $319,617
178,557 New
178,557 $149,000
Q1 2023

May 15, 2023

SELL
$1.16 - $6.41 $67,184 - $371,254
-57,918 Reduced 10.67%
484,745 $562,000
Q4 2022

Feb 14, 2023

BUY
$4.78 - $15.01 $902,798 - $2.83 Million
188,870 Added 53.38%
542,663 $2.87 Million
Q3 2022

Nov 14, 2022

SELL
$10.22 - $23.7 $498,787 - $1.16 Million
-48,805 Reduced 12.12%
353,793 $4.08 Million
Q2 2022

Aug 15, 2022

SELL
$4.35 - $15.85 $1.53 Million - $5.58 Million
-351,983 Reduced 46.65%
402,598 $4.55 Million
Q1 2022

May 16, 2022

SELL
$4.55 - $6.41 $242,323 - $341,383
-53,258 Reduced 6.59%
754,581 $3.83 Million
Q4 2021

Feb 14, 2022

BUY
$5.89 - $9.73 $403,582 - $666,699
68,520 Added 9.27%
807,839 $4.76 Million
Q3 2021

Nov 12, 2021

BUY
$6.78 - $9.89 $117,999 - $172,125
17,404 Added 2.41%
739,319 $6.31 Million
Q2 2021

Aug 16, 2021

BUY
$7.24 - $11.2 $2.76 Million - $4.26 Million
380,746 Added 111.6%
721,915 $5.83 Million
Q1 2021

May 17, 2021

BUY
$8.05 - $20.78 $656,791 - $1.7 Million
81,589 Added 31.43%
341,169 $3.68 Million
Q4 2020

Feb 16, 2021

BUY
$2.36 - $9.99 $57,777 - $244,575
24,482 Added 10.41%
259,580 $2.25 Million
Q2 2020

Aug 14, 2020

BUY
$3.01 - $4.02 $707,644 - $945,093
235,098 New
235,098 $785,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $56.9M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.